DOG1.1 is a recently described mouse monoclonal antibody reported to have superior sensitivity and specificity compared with KIT (CD117 Small subset of mesenchymal tumors like leiomyosarcoma and synovial sarcoma also show DOG1 positivity. Here, KIT is linked to mesenchymal cell neoplasm.